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Abstract
Background: Despite the growing evidence base supporting intensive lifestyle and medical treatments for severe
obesity, patient engagement in specialist obesity services is difficult to achieve and poorly understood. To address
this knowledge gap, we aimed to develop a model for predicting non-completion of a specialist multidisciplinary
service for clinically severe obesity, termed the Metabolic Rehabilitation Programme (MRP).
Method: Using a case-control study design in a public hospital setting, we extracted data from medical records for
all eligible patients with a body mass index (BMI) of ≥35 kg/m2 with either type 2 diabetes or fatty liver disease
referred to the MRP from 2010 through 2015. Non-completion status (case definition) was coded for patients whom
started but dropped-out of the MRP within 12 months. Using multivariable logistic regression, we tested the
following baseline predictors hypothesised in previous research: age, gender, BMI, waist circumference, residential
distance from the clinic, blood pressure, obstructive sleep apnoea (OSA), current continuous positive airway
pressure (CPAP) therapy, current depression/anxiety, diabetes status, and medications. We used receiver operating
characteristics and area under the curve to test the performance of models.
Results: Out of the 219 eligible patient records, 78 (35.6%) non-completion cases were identified. Significant
differences between non-completers versus completers were: age (47.1 versus 54.5 years, p < 0.001); residential
distance from the clinic (21.8 versus 17.1 km, p = 0.018); obstructive sleep apnoea (OSA) (42.9% versus 56.7%, p =
0.050) and CPAP therapy (11.7% versus 28.4%, p = 0.005). The probability of non-completion could be
independently associated with age, residential distance, and either OSA or CPAP. There was no statistically
significant difference in performance between the alternate models (69.5% versus 66.4%, p = 0.57).
Conclusions: Non-completion of intensive specialist obesity management services is most common among
younger patients, with fewer complex care needs, and those living further away from the clinic. Clinicians should
be aware of these potential risk factors for dropping out early when managing outpatients with severe obesity,
whereas policy makers might consider strategies for increasing access to specialist obesity management services.
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Background
Global trends in the prevalence of severe obesity present an
enormous clinical burden, challenging health care systems
in high-income countries [1, 2]. In Australia, the prevalence
of severe obesity defined using a body mass index (BMI) of
≥35 kg/m2 has likely tripled since 1980 [3]. Consequently,
the total direct cost (health care and non-health care) of
overweight and obesity to the Australian economy in 2005
was estimated at $21 billion annually [4]. The proportion of
the average annual health expenditure is probably 50%
higher for people with severe obesity compared to people
with a healthy BMI of 18.5 to 24.9 kg/m2 [5]. Effective obes-
ity management services for people living with from severe
obesity and its complications could return significant health
and economic benefits.
The complexity of severe obesity is challenging to
manage in the primary care setting alone, especially in
the presence of multiple medical, psychological, and
physical comorbidities [6, 7]. These complex health care
needs may be more appropriately managed in specialist
obesity services [7–9]. Specialist obesity services (or
‘clinics’) typically provide physician-led multidisciplinary
team (MDT) care utilising intensive lifestyle interven-
tions and psychological support, as well as varying levels
of access to weight-loss pharmacotherapies and bariatric
surgery [10].
There is a growing evidence base supporting the effect-
iveness of a specialist obesity services including non-
surgical MDT care, weight-loss pharmacotherapies, and
bariatric surgery for improving a range of health outcomes
in patients with clinically severe obesity [11–14]. Patients
with severe obesity lose approximately 6% of their initial
body weight after 12months of non-surgical specialist
obesity services [11, 12]. Conversely, non-completion rates
of 30–60% over this period weakens this evidence base
[15–20]. Studies have identified a number of possible pre-
dictors of non-completion such as younger age, socio-
economic disadvantaged, and less medical complications
[15–18, 20–22], as well as depression or anxiety [16, 18,
22]. Residential distance to services is likely to be another
important predictor of non-completion of specialist obes-
ity care programmes, given that musculoskeletal disorders
are highly prevalent in patients with clinically severe obes-
ity [23]. Given the substantial differences between these
treatment programmes and settings, the applicability of
this evidence in the Australian health system is unclear.
Therefore, we investigated potential predictors of non-
completion in a well-established specialist obesity service
in an Australian public hospital setting. Potential predic-
tors investigated include an extensive range of routine
data collections on demographic information, residential
distance from the clinic, anthropometry, smoking status,
medical history, medically diagnosed conditions, medica-
tion use, and glycaemic control.
Methods
We present this paper according to the STROBE guidelines
for reporting observational studies [24] and the Journal’s
formatting requirements. We previously presented the find-
ings of this research at the ANZOS-OSSANZ-AOCO Joint
Annual Scientific Meeting 2017 [25].
Study design, setting, and participants
Using a case-control study design in a public hospital set-
ting, we aimed to develop a predictive model for non-
completion of a clinical obesity service, termed the Meta-
bolic Rehabilitation Programme (MRP). The MRP is a
specialist obesity service in an outpatient public hospital
setting in the South Western Sydney Local Health District,
which covers some of the most socio-economically disad-
vantaged communities in the state of New South Wales,
Australia. Patients were referred to the MRP by medical
practitioners, including general practitioners, specialists in
hospitals, and specialists in primary care.
We extracted data from medical records for all of the
eligible patients referred to the MRP between 2010 and
2015. To be considered to enter the service during that
period, patients had to be: aged 18 years or older; have a
BMI of at least 35 kg/m2 with either type 2 diabetes and/or
fatty liver disease; and be committed to engage in the treat-
ment programme and attend regular monthly clinic ap-
pointments. Exclusion criteria were: pregnancy; conditions
associated with unintentional weight loss such as malig-
nancy; and home oxygen therapy. Though patients could
have engaged in the MRP for up to 24months, a minimum
treatment period of 12months was recommended.
Treatment programme
The MRP is an integrated physician-led MDT model of
care for managing patients with complex and severe
obesity [11, 26]. It is consistent with the model of care
recommended in our recently published expert consen-
sus, but is unique in the Australian health system in
terms of staff resources and onsite exercise supervision
[10]. Depending on the predominant complication, pa-
tients were enrolled either into the diabetes MRP or the
fatty liver MRP. Both of the MRP clinics included phys-
ician, diabetes educator (for the diabetes MRP only),
dietitian, clinical psychologist, and exercise physiologist/
physiotherapist staff resources. The two programmes
were available to patients for up to 24months, after
which they were typically discharged and referred back
to their primary care doctor. Approximately 10% of
suitable patients were referred for publicly funded bar-
iatric surgery after 12 months of MRP. Due to the high
rate of significant sleep disordered breathing discovered
in the early years of this programme, a subsidised refer-
ral pathway was established with a local sleep physician
to provide assessment and management of a clinically
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significant sleep disorder such as OSA or obesity
hypoventilation syndrome. A detailed description of the
key features of the MRP model of care has recently been
published [27].
Baseline data collections
We hand searched medical records of eligible patients
for data extraction. Informed by predictors hypothesised
in previous research [15–18, 20–22], we extracted the
following routine baseline data collections for analysis:
demographic information (age, gender, and residential
distance from the clinic); anthropometry (weight, height,
and waist circumference); and medical status including
blood pressure, number of complications, OSA, use of
current continuous positive airway pressure (CPAP)
therapy, and current use of medications. Non-alcoholic
fatty liver disease was assessed and monitored by the
hepatologist. To determine the presence of depression
and clinically severe anxiety, we used present medical
history and current use of antidepressants. We cate-
gorised smoking status data into ‘current smoker’, ‘previ-
ous smoker’, or ‘non-smoker’ groups.
Outcome data
We defined completion as patients who started and con-
tinued with the MRP for at least 12 months. As de-
scribed above, a minimum treatment period of 12
months was recommended. This duration was chosen
based on evidence from our previous research work in a
similar MRP delivered in the Sydney Local Health Dis-
trict suggesting that improvements in anthropometric
(e.g. weight-loss of 6–8%) and metabolic outcomes max-
imises at approximately 12 months [11, 26]. We also
considered findings of a recent systematic review sug-
gesting that at least 12 months of lifestyle intervention is
required to achieve clinically significant weight loss of
5–10% in patients with severe obesity [28]. Non-
completion status (case definition) was coded for pa-
tients who started but left within 12months of the MRP.
The primary outcome, non-completion of 12 months of
MRP, was coded as a binary variable.
Statistical analysis
Baseline characteristics are described using counts and
percentages for categorical variables, means and stand-
ard deviations for numeric variables, with comparisons
between groups using chi-square tests and independent
samples t-tests, respectively. We describe p-values less
than 0.05 as statistically significant and all p-values less
than 0.25 as potentially predictive [29]. To help identify
a set of key independent predictors of non-completion,
we fitted a multivariable logistic model predicting non-
completion using all predictors of interest. We started
by including four of the statistically significant predictors
(age, residential distance, OSA and CPAP), diabetes sta-
tus, insulin medication and clinically severe anxiety,
which were potentially predictive (p < 0.25) of associ-
ation. We further included depression, as we hypothe-
sised this could also impact on non-completion [16, 18,
22]. We excluded number of years since diagnosis of
diabetes, even though its p-value was < 0.25, as it was
not applicable to one third of the sample. To resolve the
potential clinical overlap between OSA and CPAP, we
report two final models: Model 1 including CPAP treat-
ment of OSA (49/113 cases); and Model 2 including the
diagnosis OSA. Missing data were noted and then
excluded from the analysis. The main analyses were
conducted using SPSS software. The relative predictive
power of the fitted models was compared based on their
received operating characteristic (ROC) curves using an




Between 2010 to 2015, 239 patients were enrolled in the
MRP. After excluding duplicate records (n = 4), baseline
BMI < 35 kg/m2 (n = 9), previous bariatric surgery (n =
3), death (n = 1), and inability to commit to the MRP de-
termined on initial consultation (n = 3), the final number
of eligible data records for analysis was for 219 partici-
pants. Within this group, 56% had entered the diabetes
MRP and 44% had entered the fatty liver MRP. Seventy-
eight patients (35.6%) were identified as non-completers.
Baseline characteristics of the MRP participants are pre-
sented both for all participants and for the 12-month
completers and non-completers separately (Table 1).
Predictors of non-completion
As shown in Table 1, we found younger age, greater resi-
dential distance from the clinic, and less complications
(OSA and CPAP) showed statistically significant evidence
of association with non-completion. We also detected
weak evidence of an association between diabetes and
non-completion. There were no significant differences
found in the other characteristics we explored.
Independence of the predictors
The probability of non-completion could have been in-
dependently associated with age, residential distance,
and either OSA or CPAP (Table 2). Our multivariate
analyse revealed that diabetes status (p = 0.893; OR 0.95,
95% CI 0.48–1.91) and then insulin (p = 0.380; OR 0.71,
95% CI 0.33–1.52) added little if any independent infor-
mation on non-completion and were removed from fur-
ther consideration. Specifically, we found diabetes status
was strongly associated with age in this population; every
additional year of age had a 5% higher odds of diabetes
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Table 1 Baseline characteristics of patient enrolled in the MPR and comparison of predictors of completer and non-completers





Age, years 52 (14) 47 (15) 55 (13) < 0.001
Gender, male 96 (44%) 37 (47%) 59 (42%) 0.42
Distance from clinic, km 19 (14) 22 (14) 17 (14) 0.018
Weight, kg 140 (38) 143 (40) 139 (37) 0.48
BMI, kg/m2 50 (11) 50 (12) 49 (11) 0.58
Obese class II (BMI ≥35.00 to 39.99) 37 (17%) 12 (15%) 25 (18%) 0.66
Obese class III (BMI ≥40.00) 182 (83%) 66 (85%) 116 (82%)
Waist circumference, cm (n = 202) 136 (19) 137 (21) 136 (18) 0.79
Smoking status 0.86
Never smoked 142 (65%) 50 (64%) 90 (65%)
Current smoker 22 (10%) 7 (9%) 15 (11%)
Previous smoker 55 (25%) 21 (27%) 34 (24%)
Systolic blood pressure, mmHg 128 (16) 127 (16) 129 (16) 0.42
Diastolic blood pressure, mmHg 76 (13) 76 (11) 76 (14) 0.86
Depression 57 (26%) 22 (28%) 35 (25%) 0.59
Anxiety 9 (4.1%) 1 (1.3%) 8 (5.7%) 0.16
OSA (n = 218) 113 (52%) 33 (42%) 80 (57%) 0.050
CPAP (n = 218) 49 (23%) 9 (12%) 40 (28%) 0.005
Diabetes (n = 218) 141 (65%) 44 (56%) 97 (69%) 0.057
No. of years since diagnosis of diabetes (n = 140) 7.8 (7.2) 6.8 (7.1) 8.3 (7.2) 0.24
Medications
Insulin 48 (22%) 13 (17%) 35 (25%) 0.16
Metformin 121 (55%) 43 (55%) 78 (55%) 0.98
No. of antihypertensive 0.68
0 66 (30.1%) 24 (30.8%) 42 (29.8%)
1 59 (26.9%) 25 (32.1%) 34 (24.1%)
2 50 (22.8%) 15 (19.2%) 35 (24.8%)
3 30 (13.7%) 9 (11.5%) 21 (14.9%)
≥ 4 14 (6.4%) 5 (6.4%) 9 (6.4%)
Blood biochemistry
HbA1c, % (n = 174) 7.1 (2.4) 7.3 (2.4) 7.1 (2.4) 0.57
HbA1c, mmol/L (n = 174) 78 (26) 80 (26) 77 (26) 0.57
Data are mean (standard deviation) unless otherwise specified; BMI body mass index; HbA1c, glycosylated haemoglobin; p-value for independent samples t-test
for continuous variables or for chi-square test for categorical variables
Table 2 Fitted models for predicting 12-month non-completion of the MRP based on patients’ baseline characteristics
Predictor Model 1 Model 2
OR (95% CI) p-value OR (95% CI) p-value
Age, years 0.96 (0.94–0.99) 0.001 0.97 (0.94–0.99) 0.001
Distance from clinic, km 1.02 (1.00–1.04) 0.065 1.02 (1.00–1.04) 0.084
CPAP 0.30 (0.13–0.68) 0.004
OSA 0.56 (0.31–1.00) 0.051
CPAP continuous positive airway pressure, OSA obstructive sleep apnoea
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diagnosis than the previous age (p < 0.001; OR 1.05, 95%
CI 1.03–1.08). We next removed depression (p = 0.576;
OR 1.22, 95%CI 0.61–2.46) and then anxiety (p = 0.265;
OR 0.29, 95% CI 0.03–2.58) from the multivariable
model because of little statistical evidence of association
and wide uncertainty in effect sizes (odds ratios). These
final fitted models are shown in Table 2. We have
retained residential distance in these models despite p-
values greater than 0.05. The relatively small p-values
and tight confidence intervals on the odds ratio suggest
it is plausible that residential distance offered some inde-
pendent information about completion.
Our results show that once you take into account
age, residential distance, and OSA or CPAP then none
of the other variables add any further information
about likelihood of non-completion. The probability of
non-completion was inversely associated with age (p =
0.001), residential distance from the clinic (p = 0.065),
and CPAP (p = 0.004) in Model 1; and inversely associ-
ated with age (p = 0.001), residential distance from the
clinic (p = 0.084), and OSA (p = 0.051) in Model 2.
There was no statistically significant difference in the
predictive power of the two models (ROC area under
curves of 69.5% versus 66.4%, p = 0.57, Fig. 1).
Discussion
This paper presents the results of the first study of
potential predictors of 12-month non-completion of an
intensive lifestyle (with supervised exercise intervention)
and medical obesity management service for patients
with severe obesity. Overall, we observed a non-
completion rate of 36%. This is approximately 20% lower
than previous studies in comparable real-world settings
over 6 and 12month periods [15, 20, 21]. This finding is
clinically useful information given that our patients typ-
ically have extremely severe obesity (mean BMI of 50;
83% with a BMI ≥40, Table 1) limiting their physical
capacity to travel to the clinic and participate in a com-
prehensive and intensive care plan which includes onsite
supervised exercise sessions 2–3 times weekly. Consist-
ent with previous research work conducted in other
countries and settings [15, 16, 20, 21], we confirmed that
younger aged patents with less medical complications
are at increased risk of dropping out of specialist obesity
services early. Despite having severe obesity, the health
needs of these younger and less complex patients might
be more appropriately addressed in primary care rather
than in specialist obesity management clinics, especially
where access to intensive services and treatments is
severely limited [10]. We also found evidence that resi-
dential distance was positively associated with non-
completion, which is broadly consistent with limited
research on this issue from studies in the US [30] and
UK [31]. There is consensus among the Australian phy-
sicians that geographical location is a major obstacle for
most patients because regular travel to the few specialist
obesity clinics located in major cities is considered pro-
hibitive [10].
Unlike some previous studies [16, 18, 22], we found no
statistical evidence that depression or anxiety predicts
dropping out of specialist obesity services early. The MRP
had included comprehensive support from a clinical
Fig. 1 ROC area under curves for fitted models (Model 1 versus Model 2)
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psychologist at the time, which might have helped some
patients with severe obesity and depression or anxiety en-
gage in the intensive specialist services and treatments
[22]. Future research is needed to confirm if comprehen-
sive psychological support is important not only for ad-
dressing the mental health issues and needs of the patient
but also for enhancing patient engagement in these ser-
vices and treatments [32]. Despite no comprehensive evi-
dence base on this issue, a range of experts agree that
MDT care should include psychologists for comprehen-
sive service delivery [7–10]. Furthermore, our observation
that the prevalence of OSA and current CPAP were posi-
tively associated with completion of the MRP is consistent
with at least one other study [20]. As with psychological
support, the MRP patients with OSA had access to a spe-
cialist sleep physician in the primary health setting, which
could have helped retain these patients. Similarly, the
provision of on-site supervised exercise in the MRP could
have also partially contributed to improvements in en-
gagement and mood among patients with depression or
anxiety. Regular exercise programmes are believed to im-
prove mood and increase physical activity level in people
with mild-to-moderate depression [33].
The results from our study have direct implications for
clinical practice. Whilst the MRP has been shown to be ef-
fective in the management of severe obesity in Australia
[11, 26], it is important to optimise the engagement of
these patients to improve their outcomes but also for the
efficacy of such services. Therefore, screening for predic-
tors of non-completion could be useful in identifying risk
factors that could be targeted with effective prevention
strategies. Existing and future obesity management clinics
should consider the potential adverse impact of the avail-
ability of specialist treatments and services on patient en-
gagement. There are enormous differences in terms of
patient access to, and composition of, specialist obesity
management services and treatments in Australia and
other countries [10, 12]. Our findings suggest that policy
makers should consider developing better access to exist-
ing clinics by improving transportation options or perhaps
exploring novel telehealth delivery of some of the treat-
ments [34], especially for rural and socio-economically
disadvantaged areas where specialist obesity management
services are absent [10].
Although this paper presents clinically important new
findings in a real-world hospital setting, they should be
interpreted with caution in consideration of several
study limitations and potential risks of bias. For instance,
our use of a case-control study design likely resulted in a
unique sample of motivated patients not representative
of the target population. The MRP entry criteria at the
time was very strict and more selective than most of the
other specialist obesity services nationwide [10]. Our pa-
tients were likely highly motivated because they were
aware of the expected commitment to the high intensity
services and treatments in the MRP. Few patients may
have also been motivated because of the possibility of
accessing publicly funded bariatric surgery after 12
months in the MRP. Although we selected a treatment
period of 12 months for our analysis of predictors based
on maximized weight-loss and metabolic outcomes from
our previous research [11, 26], a systematic review con-
cluded that weight-loss following several different life-
style and pharmacotherapies plateaus at approximately
6 months, which limits the generalizability of our find-
ings [35]. Our reliance on medical records for data ex-
tractions could have resulted in bias due to limited,
incomplete, and non-standardised information from rou-
tine baseline assessments. Consequently, we were unable
to explore a comprehensive range of potentially import-
ant reasons for non-completion. In particular, early
weight-loss response (within the first 2 months of treat-
ment) has been shown to predict weight-loss mainten-
ance at 6 and 12 months [36, 37]; completion of a
dietary-based specialist obesity service [38]; and engage-
ment in post bariatric surgery care [30]. Future research
is needed to better understand the depth and breadth of
reasons for non-completion in specialist obesity services.
Conclusions
In conclusion, our results suggest that non-completion
of intensive specialist obesity services such as the MRP
is most common among younger patients, those with
fewer complex care needs, and those living further away
from the clinic. Clinicians should be aware of these po-
tential risk factors for dropping out of specialist obesity
management services early when managing outpatients
with severe obesity, whereas policy makers might con-
sider strategies for increasing access to specialist obesity
management services by improving transportation op-
tions or perhaps exploring novel telehealth delivery of
some of the treatments, especially for areas where such
services do not exist.
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